Imdelltra (amg757) Kit
Product Images NDC 55513-059

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Imdelltra (amg757) (NDC 55513-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Kit Package)

Principal Display Panel (Kit Package)
This text contains information about the drug Imrelltra, a single-dose vial containing 1 mg/vial of tarlatamab-dlle. The drug must be reconstituted with sterile water for intravenous infusion after dilution. It also includes storage instructions to keep refrigerated at 2-8°C (36-46°F) in the original carton to protect from light until use. Additionally, it mentions that the drug should not be frozen and provides guidance to dispense the enclosed medication guide to each patient.*
FDA Label Image

Principal Display Panel (Kit Package)

Principal Display Panel (Kit Package)
This is a label for IMDELLTRA™, a medication by AMGEN®, containing a single-dose vial and solution stabilizer vials for injection and further intravenous infusion after dilution. It must be stored refrigerated at 2°C to 8°C (36°F to 46°F) and protected from light until use. The medication should not be frozen, and the enclosed medication guide should be dispensed to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.